These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 19635229

  • 1. Role of interventional radiology in the treatment of patients with neuroendocrine metastases in the liver.
    Kvols LK, Turaga KK, Strosberg J, Choi J.
    J Natl Compr Canc Netw; 2009 Jul; 7(7):765-72. PubMed ID: 19635229
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.
    Atwell TD, Charboneau JW, Que FG, Rubin J, Lewis BD, Nagorney DM, Callstrom MR, Farrell MA, Pitot HC, Hobday TJ.
    Cardiovasc Intervent Radiol; 2005 Jul; 28(4):409-21. PubMed ID: 16041556
    [Abstract] [Full Text] [Related]

  • 4. Update on the management of neuroendocrine hepatic metastases.
    Madoff DC, Gupta S, Ahrar K, Murthy R, Yao JC.
    J Vasc Interv Radiol; 2006 Aug; 17(8):1235-49; quiz 1250. PubMed ID: 16923972
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Management of advanced neuroendocrine tumors with hepatic metastasis.
    Khasraw M, Gill A, Harrington T, Pavlakis N, Modlin I.
    J Clin Gastroenterol; 2009 Oct; 43(9):838-47. PubMed ID: 19654558
    [Abstract] [Full Text] [Related]

  • 7. Management of patients with hepatic metastases from neuroendocrine tumors.
    Clift AK, Frilling A.
    Ann Saudi Med; 2014 Oct; 34(4):279-90. PubMed ID: 25811199
    [Abstract] [Full Text] [Related]

  • 8. Radioembolization in the treatment of neuroendocrine tumors of the pancreas.
    John PK, Saif MW.
    JOP; 2014 Jul 28; 15(4):332-4. PubMed ID: 25076336
    [Abstract] [Full Text] [Related]

  • 9. Interventional radiology for hepatocellular carcinoma.
    Loffroy R.
    Minerva Gastroenterol Dietol; 2011 Sep 28; 57(3):299-309. PubMed ID: 21769079
    [Abstract] [Full Text] [Related]

  • 10. Interventional Oncology: Optimizing Transarterial Therapies for the Treatment of Hepatic Malignancy.
    Kouri BE.
    Tech Vasc Interv Radiol; 2018 Dec 28; 21(4):205-222. PubMed ID: 30545499
    [Abstract] [Full Text] [Related]

  • 11. Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis.
    Egger ME, Armstrong E, Martin RC, Scoggins CR, Philips P, Shah M, Konda B, Dillhoff M, Pawlik TM, Cloyd JM.
    J Am Coll Surg; 2020 Apr 28; 230(4):363-370. PubMed ID: 32032719
    [Abstract] [Full Text] [Related]

  • 12. [Radiologically guided interventional therapies for the treatment of neuroendocrine tumors].
    Radosa CG, Nebelung H, Schön F, Hoffmann RT.
    Radiologie (Heidelb); 2024 Jul 28; 64(7):575-581. PubMed ID: 38761204
    [Abstract] [Full Text] [Related]

  • 13. [Interventional radiology of liver tumors].
    Piron L, Cassinotto C, Guiu B.
    Presse Med; 2019 Oct 28; 48(10):1156-1168. PubMed ID: 31672452
    [Abstract] [Full Text] [Related]

  • 14. Ablative therapies for liver metastases of gastroenteropancreatic endocrine tumors.
    Ruszniewski P, O'Toole D.
    Neuroendocrinology; 2004 Oct 28; 80 Suppl 1():74-8. PubMed ID: 15477722
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Transarterial liver-directed therapies of neuroendocrine hepatic metastases.
    Nazario J, Gupta S.
    Semin Oncol; 2010 Apr 28; 37(2):118-26. PubMed ID: 20494704
    [Abstract] [Full Text] [Related]

  • 17. Radiofrequency ablation of neuroendocrine hepatic metastasis.
    Gamblin TC, Christians K, Pappas SG.
    Surg Oncol Clin N Am; 2011 Apr 28; 20(2):273-9, vii-viii. PubMed ID: 21377583
    [Abstract] [Full Text] [Related]

  • 18. Interventional radiology in the treatment of hepatic metastases.
    Adam A.
    Cancer Treat Rev; 2002 Apr 28; 28(2):93-9. PubMed ID: 12297117
    [Abstract] [Full Text] [Related]

  • 19. Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis.
    Shaheen M, Hassanain M, Aljiffry M, Cabrera T, Chaudhury P, Simoneau E, Kongkaewpaisarn N, Salman A, Rivera J, Jamal M, Lisbona R, Khankan A, Valenti D, Metrakos P.
    HPB (Oxford); 2012 Jan 28; 14(1):60-6. PubMed ID: 22151453
    [Abstract] [Full Text] [Related]

  • 20. Treatment options for unresectable neuroendocrine liver metastases.
    John BJ, Davidson BR.
    Expert Rev Gastroenterol Hepatol; 2012 Jun 28; 6(3):357-69. PubMed ID: 22646257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.